A healthy 46-year-old man developed jaundice and liver enzyme elevations soon after starting telithromycin therapy. He improved after the drug was withdrawn. A 51-year-old healthy woman developed jaundice and enzyme elevations the week after starting telithromycin. Her condition worsened, and she required liver transplantation to survive. Examination of her liver suggested drug-related liver failure. A 26-year-old man who drank alcohol regularly developed jaundice, fever, and gastrointestinal bleeding the week after starting telithromycin therapy. His condition quickly worsened, and he died. Examination of his liver also suggested drug-related liver failure. In a review of available information, the authors found that telithromycin was a known cause of mild liver enzyme elevations. However, there was no evidence that telithromycin caused mild elevations more often than other antibiotics. There were also no reported cases of elevations or liver damage as serious as those in the 3 patients.